How well do office and exercise blood pressures predict sustained hypertension? A Dundee Step Test Study

Similar documents
The problem of uncontrolled hypertension

Slide notes: References:

Echocardiographic definition of left ventricular hypertrophy in the hypertensive: which method of indexation of left ventricular mass?

& Wilkins. a Division of Cardiology, Schulich Heart Centre, b Institute for Clinical and

Prognostic significance of blood pressure measured in the office, at home and during ambulatory monitoring in older patients in general practice

DIFFERENTE RELAZIONE TRA VALORI PRESSORI E MASSA VENTRICOLARE SX NEI DUE SESSI IN PAZIENTI IPERTESI.

Hypertension is a common medical disorder, affecting. Is Resistant Hypertension Really Resistant? Mark A. Brown, Megan L. Buddle, and Allison Martin

Importance of Ambulatory Blood Pressure Monitoring in Adolescents

ANTIHYPERTENSIVE DRUG THERAPY IN CONSIDERATION OF CIRCADIAN BLOOD PRESSURE VARIATION*

High-dose monotherapy vs low-dose combination therapy of calcium channel blockers and angiotensin receptor blockers in mild to moderate hypertension

ORIGINAL ARTICLE AMBULATORY BLOOD PRESSURE IN OBESITY. Introduction. Patients and Methods

BRIEF COMMUNICATIONS. KEY WORDS: Ambulatory blood pressure monitoring, placebo effect, antihypertensive drug trials.

Risk Factors for Ischemic Stroke: Electrocardiographic Findings

Prevalence of left ventricular hypertrophy in a hypertensive population

University of Padova, Padua, Italy, and HARVEST Study Group, Italy

Trough to peak ratio: current status and applicability

The magnitude and duration of ambulatory blood pressure reduction following acute exercise

Comparison of arbitrary definitions of circadian time periods with those determined by wrist actigraphy in analysis of ABPM data

Does the reduction in systolic blood pressure alone explain the regression of left ventricular hypertrophy?

CARDIOVASCULAR RISK FACTORS & TARGET ORGAN DAMAGE IN GREEK HYPERTENSIVES

Unreliable oscillometric blood pressure measurement: prevalence, repeatability and characteristics of the phenomenon

Prognostic significance of blood pressure measured on rising

Younger adults with a family history of premature artherosclerotic disease should have their cardiovascular risk factors measured.

Hospital and 1-year outcome after acute myocardial infarction in patients with diabetes mellitus and hypertension

THE NEW ARMENIAN MEDICAL JOURNAL DISTRIBUTION, AWARENESS, TREATMENT, AND CONTROL OF ARTERIAL HYPERTENSION IN YEREVAN (ARMENIA)

Baroreflex sensitivity and the blood pressure response to -blockade

Drug treatments in hypertension outcome studies

Egyptian Hypertension Guidelines

DIURNAL VARIATIONS IN BLOOD PRESSURE AND THEIR RELATION WITH CAROTID ARTERY INTIMA-MEDIA THICKENING

Incidental Findings; Management of patients presenting with high BP. Phil Swales

The Evolution To Treatment Of Hypertension With Advanced Formulation

1. Department of Gynecology and Obstetrics, St. Joseph's Hospital Berlin Tempelhof, Germany

Validation of the SEJOY BP-1307 upper arm blood pressure monitor for home. blood pressure monitoring according to the European Society of Hypertension

The Conduit Artery Functional Endpoint (CAFE) study in ASCOT

Dr. A. Manjula, No. 7, Doctors Quarters, JLB Road, Next to Shree Guru Residency, Mysore, Karnataka, INDIA.

Is Traditional Clinic Blood Pressure Dead?

Internet Journal of Medical Update, Vol. 3, No. 2, Jul-Dec 2008

ESM1 for Glucose, blood pressure and cholesterol levels and their relationships to clinical outcomes in type 2 diabetes: a retrospective cohort study

Night time blood pressure and cardiovascular structure in a middle-aged general population in northern Italy: the Vobarno Study

Blood Pressure and Complications in Individuals with Type 2 Diabetes and No Previous Cardiovascular Disease. ID BMJ

Primary hypertension in adults

J-curve Revisited. An Analysis of Blood Pressure and Cardiovascular Events in the Treating to New Targets (TNT) Trial

Blood Pressure Response Under Chronic Antihypertensive Drug Therapy

The incidence of transient myocardial ischemia,

Difficult-to-Control & Resistant Hypertension. Anthony Viera, MD, MPH, FAHA Professor and Chair

5.2 Key priorities for implementation

1.4 - Linear Regression and MS Excel

Prevention of Heart Failure: What s New with Hypertension

White coat and masked hypertension

Todd S. Perlstein, MD FIFTH ANNUAL SYMPOSIUM

Hypertension Update Warwick Jaffe Interventional Cardiologist Ascot Hospital

Normal Ambulatory Blood Pressure: A Clinical-Practice- Based Analysis of Recent American Heart Association Recommendations

AGING, BLOOD PRESSURE & CARDIOVASCULAR DISEASE EVENT RISK. Michael Smolensky, Ph.D. The University of Texas Austin & Houston

AT 1 -receptor blockers: differences that matter

Summary of recommendations

Management of Hypertension in special groups. DR-Mohammed Salah Assistant Lecturer of Cardiology Mansoura University

High-Normal Blood Pressure Progression to Hypertension in the Framingham Heart Study

Ambulatory BP Monitoring: Getting the Diagnosis of Hypertension Right. Anthony J. Viera, MD, MPH, FAHA Professor and Chair

1 Department of Medical Physics, Royal Infirmary of Edinburgh, 2 Department of. Received 11 June 2004 Accepted 7 September 2004

Left ventricular mass in offspring of hypertensive parents: does it predict the future?

Ambulatory blood pressure monitoring is key to improving hypertension diagnosis

Antihypertensive efficacy of olmesartan compared with other antihypertensive drugs

Time of day for exercise on blood pressure reduction in dipping and nondipping hypertension

Hypertension and Cardiovascular Disease

Appendix F: Clinical evidence tables

Large therapeutic studies in elderly patients with hypertension

HOW CONSISTENT ARE THE BLOOD PRESSURE AND PULSE RATE MEASUREMENTS OF THE ELECTRONIC BP APPARATUS AND THE MANUAL SPHYGMOMANOMETER

DISCLOSURES OUTLINE OUTLINE 9/29/2014 ANTI-HYPERTENSIVE MANAGEMENT OF CHRONIC KIDNEY DISEASE

Overview of the outcome trials in older patients with isolated systolic hypertension

THE ACCURATE ASSESSMENT

Reversible hypertension following coeliac disease treatment: the role of moderate hyperhomocysteinaemia and vascular endothelial dysfunction

Hypertension is a risk factor for coronary

The hypertensive effects of the renin-angiotensin

ADVANCES IN MANAGEMENT OF HYPERTENSION

There is convincing evidence in clinical studies

Preventing the cardiovascular complications of hypertension

What s In the New Hypertension Guidelines?

Risk Assessment of developing type 2 diabetes mellitus in patient on antihypertensive medication

and bias, which are known to be present in self-home and in professional office BP measurements taken using the auscultatory technique [7].

4/4/17 HYPERTENSION TARGETS: WHAT DO WE DO NOW? SET THE STAGE BP IN CLINICAL TRIALS?

ORIGINAL INVESTIGATION. C-Reactive Protein Concentration and Incident Hypertension in Young Adults

IRBES_R_04320 Generic drug name: Irbesartan + amlodipine Date: Study Code: 31 active centers: 20 in Korea, 7 in India and 4 in Philippines.

Assessing Blood Pressure for Clinical Research: Pearls & Pitfalls

ADVANCES IN MANAGEMENT OF HYPERTENSION

combination (97 ± 8 beats min-'; 65 ± 4 beats cardiac output may be balanced by the vasodilatation

Update on HTN and ABPM. Raj Padwal Division of General Internal Medicine University of Alberta

Verapamil SR and trandolapril combination therapy in hypertension a clinical trial of factorial design

Hypertension Putting the Guidelines into Practice

ESSENTIAL HYPERTENSION

DISCLOSURE PHARMACIST OBJECTIVES 9/30/2014 JNC 8: A REVIEW OF THE LONG-AWAITED/MUCH-ANTICIPATED HYPERTENSION GUIDELINES. I have nothing to disclose.

ASSOCIATION OF SYSTEMIC INFLAMMATION WITH ARTERIAL STIFFNESS IN HYPERTENSION

Copyright Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.

National Horizon Scanning Centre. Irbesartan (Aprovel) for prevention of cardiovascular complications in patients with persistent atrial fibrillation

Setting The setting was primary care. The economic study was carried out in the UK and the USA.

Stroke A Journal of Cerebral Circulation

47 Hypertension in Elderly

Diltiazem use in tacrolimus-treated renal transplant recipients Kothari J, Nash M, Zaltzman J, Prasad G V R

Research. A comparison of blood pressure measurement over a sleeved arm versus a bare arm. The measurement of blood pressure is one of the

Blood Pressure Targets: Where are We Now?

FOR many years, casual blood pressure (BP)

Transcription:

(2000) 14, 429 433 2000 Macmillan Publishers Ltd All rights reserved 0950-9240/00 $15.00 www.nature.com/jhh ORIGINAL ARTICLE How well do office and exercise blood pressures predict sustained hypertension? PO Lim, PT Donnan and TM MacDonald Hypertension Research Centre, Department of Clinical Pharmacology and Therapeutics, University of Dundee, Ninewells Hospital and Medical School, Dundee DD1 9SY, UK Exercise systolic blood pressure (BP) appears to be a better predictor of cardiac mortality than casual office BP. We tested whether this could be explained by exercise systolic BP being a better predictor of sustained hypertension than casual office BP. Exercise systolic BP was measured using the lightweight 3-min single stage, submaximal Dundee Step Test in 191 consecutive subjects (102 male, age 52 (s.d. 13) years) who were referred to a specialist hypertension clinic for assessment. Exercise systolic BP was compared with office BP and daytime ambulatory BP (ABP). Sustained hypertension was defined as a mean daytime systolic and/or diastolic ABP of 140/90 mm Hg. Receiver operating characteristic (ROC) curves of exercise systolic BP and office BP in predicting sustained hypertension were compared. The positive predictive value of office diastolic BP 90 mm Hg and office systolic BP 140 mm Hg for sustained hypertension were 64% and 67% respectively. However, exercise systolic BP 180 mm Hg had a positive predictive value of 76%. Twentytwo percent (42/191) of subjects had an exercise systolic BP rise to 210 mm Hg, and 93% of this group had sustained hypertension on ABP. Whilst exercise systolic BP was a better predictor of sustained hypertension using currently recommended office BP treatment thresholds, the ROC curves of these indices were not different. In a multiple regression analysis, exercise systolic BP was an independent predictor of sustained hypertension, accounting for 36% of the variance of daytime systolic ABP after adjusting for age, gender and antihypertensive drug treatment. In conclusion, exercise systolic BP was a marginally better predictor of sustained hypertension than office BP. This may partly explain why exercise systolic BP is a potent predictor of cardiac mortality. (2000) 14, 429 433 Keywords: exercise; hypertension; diagnosis; blood pressure Introduction Resting blood pressure (BP) measured in the office setting does not always reflect the BP profile throughout the day, especially when an individual leads an active life. This problem with office BP is further compounded by the presence of the white coat effect, that is, the reactive rise in BP that occurs in the office environment. 1 This effect is present in subjects with white coat hypertension and also occurs in sustained hypertension where it complicates therapeutic decision making. 2,3 Whether hypertension should continue to be managed by measuring office BP is increasingly being questioned. 4 6 Ambulatory BP monitoring (ABP) allows the assessment of BP over a more prolonged period, and the mean of ABP readings correlates more closely with target organ damage 2,7 and outcome. 6 However, ABP is expensive, uncomfortable, and usually only available in specialist centres. 8 Another potential BP assessment method is the exercise BP. Correspondence: Dr Pitt O Lim, Department of Clinical Pharmacology and Therapeutics, University of Dundee, Ninewells Hospital and Medical School, Dundee DD1 9SY, UK Received 14 January 2000; revised and accepted 27 March 2000 Although exercise BP has been shown to be more potent than casual office BP in predicting target organ damage 9 and of cardiac mortality, 10,11 it has not yet entered clinical practice. We have assessed the diagnostic value of exercise BP, obtained using the 3-min Dundee Step Test, 12 and office BP, in predicting whether sustained hypertension was present in a population of patients referred to a specialist hypertension clinic. Subjects and methods Participants We studied consecutive subjects referred to our specialist hypertension clinic during a 14-month period between May 1998 and July 1999. These subjects all had raised office BP readings ( 160/90 mm Hg) confirmed over a period of at least 3 months prior to their referral by primary-care physicians. We excluded subjects who were unable to exercise or who had seated office systolic BP 200 mm Hg. Prior to being studied, subjects who were taking antihypertensive therapy had their treatment withdrawn for at least 1 week if there were no contraindications, such as previous history of accelerated

430 hypertension, ischaemic heart disease or cerebrovascular disease. Blood pressure measurements BP was measured in triplicate by trained hypertension research nurses using a standard mercury sphygmomanometer at 1-min intervals after patients had been sitting quietly for 2 min. The mean of these three readings was used to define office BP. Each patient then underwent a 3-min single-stage submaximal Dundee Step Test, the methodology of which has been described elsewhere. 12 An ABP (Spacelabs 90207, Redmond, WA, USA) was then obtained from each patient on an active day. 13 Daytime (08.00 22.00, BP sampling every 15 min) mean systolic ABP of 140 mm Hg and/or mean diastolic ABP of 90 mm Hg defined sustained hypertension. Statistical methods Data on BPs were recorded as mean and standard deviation. The sensitivity, specificity and positive predictor value (PPV) for levels of ABP predicted by different thresholds of office BP and exercise systolic BP were calculated and tabulated. The relationship between systolic ABP, office systolic BP and exercise systolic BP were assessed in a multiple linear regression with systolic ABP as outcome. 2,6,7 The assessment of fit was given by the value of the R- squared, that is, the proportion of variability of the outcome explained by the predictor(s). Possible confounding variables adjusted for in the regression analysis were age, gender, and an indicator of whether drug treatment continued or had been stopped. In order to assess the assumption of normality for the outcome in the regression analysis, the studentised residuals were plotted against the predicted systolic ABP. A linear relationship was assumed for predictors with the systolic ABP. The functional form of this relationship was assessed by fitting a cubic smoothing spline. 14 All statistical analyses were carried out using SAS version 6.12. Results General characteristics We studied 191 consecutive hypertension clinic referrals (102 male, mean age 52 (s.d. 13) years). Of that number, 62.3% (119/191) of subjects were assessed taking no drug treatment. Sustained hypertension on ABP was present in 61.3% (117/191) of subjects. The remaining patients either had white coat hypertension, were normotensive on no treatment or had controlled treated hypertension. The mean (s.d.) office, exercise systolic and ambulatory BP values of the study population were 168 (23)/103 (11) mm Hg, 187 (27) mm Hg and 143 (16)/89 (11) mm Hg respectively. Prediction of sustained hypertension The current standard in research and practice, ie, an office diastolic BP 90 mm Hg had a sensitivity of 96% but a very low specificity of 12% in predicting sustained hypertension (Table 1). Office systolic BP also had low specificity. Exercise systolic BP had better predictive power of 76% if the threshold of 180 mm Hg 12 was exceeded and even better if 210 mm Hg was exceeded. The PPV of exercise systolic BP was higher than that of office diastolic or systolic BPs at the recommended treatment thresholds. The use of exercise systolic BP of 180 mm Hg thus represented nearly a 20% gain in diagnostic power over that of office diastolic BP ( 90 mm Hg) in our study population. Excluding subjects with isolated systolic hypertension (systolic ABP 140 mm Hg and diastolic ABP 90 mm Hg, n = 29) and isolated diastolic hypertension (systolic ABP 140 mm Hg and diastolic ABP 90 mm Hg, n = 6) did not significantly alter the sensitivity or specificity of either office BP or exercise BP. By increasing the exercise systolic BP threshold to 210 mm Hg, the PPV improved to 93%, represented by 22% (42/191) of the study population. The further a receiver operating characteristic (ROC) curve bends toward the left upper corner of the graph, the more discriminating was the test (Figure 1). There appeared to be a trend in the order of exercise systolic BP, office systolic BP and office diastolic BP in better predicting sustained hypertension. However, the ROC curves of these indices were not different, with areas under the ROC curves of 0.776, 0.764 and 0.748 for exercise systolic BP, office systolic BP and office diastolic BP respectively. Regression analysis Variables were entered in a multiple linear regression. Plots of the residuals against predicted systolic ABP showed that these were approximately normally distributed. When office systolic BP was regressed on systolic ABP as outcome there was a highly significant (P 0.0001) positive relationship. Table 1 Blood pressure thresholds and the prediction of the presence of sustained hypertension BP thresholds (mm Hg) Sensitivity (%) Specificity (%) Positive predictive value (%) Office BP measurements Diastolic BP 90 96 12 64 Systolic BP 140 97 22 67 150 93 42 72 160 77 60 75 Exercise systolic BP 180 80 59 76 210 33 96 93

431 Figure 1 Receiver operating characteristic curves (ROC) for exercise systolic blood pressure and office blood pressure in predicting sustained hypertension. Office systolic BP accounted for 33% of the variation in systolic ABP. However, when exercise systolic BP alone was regressed on systolic ABP, this was also highly significant (P 0.0001) with an increased amount of variation explained (36%). An increase of 10 mm Hg in exercise systolic BP was associated with an increase of 3.7 mm Hg in mean daytime systolic ABP. Adjusting for age, gender, and drug treatment did not appreciably change the significance of these results. When these factors were considered individually, only age was weakly but significantly associated with systolic ABP (R 2 = 2.4%, P = 0.018). Neither gender (P = 0.073) nor drug treatment (P = 0.173) were significantly associated with systolic ABP. When office systolic BP and exercise systolic BP were assessed simultaneously as predictors of systolic ABP, both variables remained statistically significant in the multiple linear regression adjusting for age, gender and treatment (Table 2). The partial correlation coefficient between exercise systolic BP and systolic ABP after adjusting for office BP was 0.28. When the office BP residuals after regression on systolic ABP was plotted against exercise systolic BP residuals after regression on systolic ABP, a significant correlation was also found (r = 0.885, P 0.001). Thus, exercise systolic BP was a significant predictor of ABP, independently of office systolic BP despite the high collinearity Figure 2 Exercise systolic blood pressure as a linear predictor of mean daytime systolic ambulatory blood pressure. between these two indices. Figure 2 shows the regression line obtained. Fitting a smoothed cubic spline demonstrated that the assumption of an approximate linear relationship was justified. Discussion Exercise BP obtained using the 3-min Dundee Step Test provided marginally greater diagnostic certainty in determining whether an individual has sustained hypertension. This is in contrast with office BP which had very low specificity for sustained hypertension, suggesting that it lacked the ability to discriminate against the white coat effect. The independent predictive value of exercise BP is relevant because systolic ABP has consistently been shown to have greater prognostic value than office BP or diastolic ABP. 2,7 The prognostic value of exercise BP may thus be partly explained by its ability to predict the daily BP load which causes target organ damage. Exercise testing also helps to identify treated hypertensive patients with controlled resting office BP, but uncontrolled exercise BP, 15 who may continue to have further target organ damage and adverse outcome. 16 18 An exercise test may unmask abnormal underlying haemodynamics pathognomonic of the hypertension disease process. Hypertensive individuals have impaired peripheral vasodilation during exercise and this leads to uncontrolled BP rise. 9 Table 2 Results of adjusted and unadjusted linear regression on systolic ABP as outcome Predictor Unadjusted P-value R 2 Adjusted P-value R 2 regression regression coefficient coefficient (s.e.) (s.e.) Office systolic BP 0.409 (0.042) 0.0001 0.33 0.214 (0.068) 0.002 0.39 Exercise systolic BP 0.374 (0.036) 0.0001 0.36 0.218 (0.059) 0.0003 0.39 Age 0.221 (0.093) 0.018 0.02 0.014 (0.087) 0.869 0.39 Gender 4.312 (2.385) 0.072 0.01 2.963 (1.902) 0.121 0.39 Treatment 3.500 (2.481) 0.160 0.01 2.101 (2.177) 0.336 0.39 s.e., standard error.

432 Importantly, exercise BP relates better to cardiac mortality 10,11 than office BP, and it also identified normotensive individuals who are more likely to develop hypertension in the future. 9,19 Furthermore, exercise BP may assess the sum total of the effects of traditional coronary risk factors such as hypercholestrolaemia and glucose intolerance on the peripheral vasculature. 20 Whether treating hypertension guided by exercise BP improves outcome is currently being assessed in a randomised controlled trial which will report in 5 years time. 21 Our study population was limited to patients referred for hypertension assessment in a tertiary centre. Hence the findings of this study cannot be extrapolated to the general population. Others 9,19 however have assessed exercise BP in the general population and have found that it is of prognostic value over and above that of office BP. It is likely that our findings would be reproducible in the wider population. Nonetheless, routine exercise BP assessment can not be recommended at present to detect sustained hypertension in clinical practice as its value over that of office BP was only marginal, and it was dependent on the treatment thresholds. Furthermore, the office BP in this study was not assessed on multiple occasions which might increase its predictive value of sustained hypertension although in some patients the white coat effect might not habituate even with repeated visits, therefore the need for ABP. The assessment of office BP and exercise BP in this study was not randomised, but was sequential within a single visit in each patient. As such, it was unlikely that a learning effect for exercise BP measurement would have occurred. Even if it did, this would be minor and systematic in nature. About one-third of patients were assessed on treatment. Again, this should not represent a methodological issue since the primary objective of the study was to relate office and exercise BPs to ABP within individuals, irrespective of the treatment status. In other words, the fact that each patient had all the BP assessments (office BP, exercise BP and ABP) done at the same visit, each patient effectively acted as his or her own control. However, beta-blockade in particular would blunt BP rise during exercise, hence beta-blockers could potentially reduce the predictive value of exercise BP in defining sustained hypertension. Reassuringly, the multiple regression analysis suggested that drug treatment as a whole did not influence our findings although our study was not designed to assess the effect of individual drugs on office or exercise BPs. Conclusions Exercise BP measured using the Dundee Step Test was a marginally better predictor of sustained hypertension at the currently recommended treatment thresholds for office BP. Contributors POL and TMM conceived, carried out the project and prepared the manuscript. PTD analysed the data and took part in preparing the final draft. Acknowledgements We thank Hazel Mudie for helping to collect the data, and the Scottish Office and Anonymous Trust for funding this project. References 1 Prasad N, MacFadyen RJ, Ogston SA, MacDonald TM. Elevated blood pressure during the first two hours of ambulatory blood pressure monitoring: a study comparing consecutive twenty-four-hour monitoring periods. J Hypertens 1995; 13: 291 295. 2 Cuspidi C et al. Blood pressure control in a hypertension hospital clinic. J Hypertens 1999; 17: 835 841. 3 Myers MG, Reeves RA. White coat phenomenon in patients receiving antihypertensive therapy. Am J Hypertens 1991; 4: 844 849. 4 Clement DL, De Buyzere M. Office versus Ambulatory (OvA) recording of blood pressure, a European multicenter study: inclusion and early follow-up characteristics. Blood Press Monit 1998; 3: 167 172. 5 Inden Y et al. Relationship between Joint National Committee-VI classification of hypertension and ambulatory blood pressure in patients with hypertension diagnosed by casual blood pressure. Clin Cardiol 1998; 21: 801 806. 6 Staessen JA et al. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investigators. JAMA 1999; 282: 539 546. 7 Mancia G et al. Ambulatory blood pressure is superior to clinic blood pressure in predicting treatmentinduced regression of left ventricular hypertrophy. SAMPLE Study Group. Study on Ambulatory Monitoring of Blood Pressure and Lisinopril Evaluation. Circulation 1997; 95: 1464 1470. 8 Staessen JA et al. Antihypertensive treatment based on conventional or ambulatory blood pressure measurement. A randomized controlled trial. Ambulatory Blood Pressure Monitoring and Treatment of Hypertension Investigators. JAMA 1997; 278: 1065 1072. 9 Lim PO, MacFadyen RJ, Clarkson PB, MacDonald TM. Impaired exercise tolerance in hypertensive patients. Ann Intern Med 1996; 124: 41 55. 10 Mundal R et al. Exercise blood pressure predicts cardiovascular mortality in middle-aged men. Hypertension 1994; 24: 56 62. 11 Filipovsky J, Ducimetiere P, Safar ME. Prognostic significance of exercise blood pressure and heart rate in middle-aged men. Hypertension 1992; 20: 333 339. 12 Lim PO, Shiels P, Anderson JE, MacDonald TM. Dundee Step Test: a simple method of measuring the blood pressure response to exercise. J Hum Hypertens 1999; 13: 521 526. 13 Devereux RB et al. Left ventricular hypertrophy in patients with hypertension: importance of blood pressure response to regularly recurring stress. Circulation 1983; 68: 470 476. 14 Hastie TJ, Tibshirani RJ. Generalized Additive Models. Chapman and Hall: London, 1990. 15 Lim PO, Shiels P, MacDonald TM. The Dundee Step Test: a novel exercise test suitable for the outpatient management of hypertension. J Hypertens 1998; 16: 1701. 16 Isles CG et al. Mortality in patients of the Glasgow Blood Pressure Clinic. J Hypertens 1986; 4: 141 156. 17 Lindholm L, Ejlertsson G, Schersten B. High risk of cerebro-cardiovascular morbidity in well treated male hypertensives. A retrospective study of 40 59-year-old

hypertensives in a Swedish primary care district. Acta Med Scand 1984; 216: 251 259. 18 Andersson OK et al. Survival in treated hypertension: follow up study after two decades. BMJ 1998; 317: 167 171. 19 Singh JP et al. Blood pressure response during treadmill testing as a risk factor for new-onset hypertension: the Framingham Heart Study. Circulation 1999; 99: 1831 1836. 20 Mundal R et al. Clustering of coronary risk factors with increasing blood pressure at rest and during exercise. J Hypertens 1998; 16: 19 22. 21 Lim PO, Donnan PT, MacDonald TM. Does the Dundee Step Test predict outcome in treated hypertension? A sub-study protocol for the ASCOT trial. J Hum Hypertens 2000; 14: 75 78. 433